Literature DB >> 11119646

Energy landscape theory for Alzheimer's amyloid beta-peptide fibril elongation.

F Massi1, J E Straub.   

Abstract

Recent experiments on the kinetics of deposition and fibril elongation of the Alzheimer's beta-amyloid peptide on preexisting fibrils are analyzed. A mechanism is developed based on the dock-and-lock scheme recently proposed by Maggio and coworkers to organize their experimental observations of the kinetics of deposition of beta-peptide on preexisting amyloid fibrils and deposits. Our mechanism includes channels for (1) a one-step prion-like direct deposition on fibrils of activated monomeric peptide in solution, and (2) a two-step deposition of unactivated peptide on fibrils and subsequent reorganization of the peptide-fibril complex. In this way, the mechanism and implied "energy landscape" unify a number of schemes proposed to describe the process of fibril elongation. This beta-amyloid landscape mechanism (beta ALM) is found to be in good agreement with existing experimental data. A number of experimental tests of the mechanism are proposed. The mechanism leads to a clear definition of overall equilibrium or rate constants in terms of the energetics of the elementary underlying processes. Analysis of existing experimental data suggests that fibril elongation occurs through a two-step mechanism of nonspecific peptide absorption and reorganization. The mechanism predicts a turnover in the rate of fibril elongation as a function of temperature and denaturant concentration. Proteins 2001;42:217-229. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119646     DOI: 10.1002/1097-0134(20010201)42:2<217::aid-prot90>3.0.co;2-n

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  37 in total

1.  Exploring protein aggregation and self-propagation using lattice models: phase diagram and kinetics.

Authors:  R I Dima; D Thirumalai
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

2.  Formation of partially ordered oligomers of amyloidogenic hexapeptide (NFGAIL) in aqueous solution observed in molecular dynamics simulations.

Authors:  Chun Wu; Hongxing Lei; Yong Duan
Journal:  Biophys J       Date:  2004-08-23       Impact factor: 4.033

3.  Aqueous urea solution destabilizes Abeta(16-22) oligomers.

Authors:  D K Klimov; John E Straub; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

4.  Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

5.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

6.  Monomer adds to preformed structured oligomers of Abeta-peptides by a two-stage dock-lock mechanism.

Authors:  Phuong H Nguyen; Mai Suan Li; Gerhard Stock; John E Straub; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

7.  Hydrophobic cooperativity as a mechanism for amyloid nucleation.

Authors:  Ronald D Hills; Charles L Brooks
Journal:  J Mol Biol       Date:  2007-02-24       Impact factor: 5.469

8.  Probing the mechanisms of fibril formation using lattice models.

Authors:  Mai Suan Li; D K Klimov; J E Straub; D Thirumalai
Journal:  J Chem Phys       Date:  2008-11-07       Impact factor: 3.488

9.  Dynamics of locking of peptides onto growing amyloid fibrils.

Authors:  Govardhan Reddy; John E Straub; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

Review 10.  Biomolecular Assemblies: Moving from Observation to Predictive Design.

Authors:  Corey J Wilson; Andreas S Bommarius; Julie A Champion; Yury O Chernoff; David G Lynn; Anant K Paravastu; Chen Liang; Ming-Chien Hsieh; Jennifer M Heemstra
Journal:  Chem Rev       Date:  2018-10-03       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.